Accretion Nutraveda IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jan 28 to Jan 30 2026
Price Band
₹122 - 129
Current GMP
₹191.0 (+48.06%)
Subscription
1.83 times
IPO Details
| IPO Date | 28 to 30 Jan, 2026 |
| Listing Date | Wed, Feb 4, 2026 T |
| Face Value | ₹ 10 per share |
| Price Band | ₹122 to ₹129 |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Total Issue Size | 19,20,000 shares (agg. up to ₹ 25 Cr) |
| Reserved for Market Maker | 96,000 shares (agg. up to ₹ 1 Cr) Sunflower Broking Pvt.Ltd. |
| Net Offered to Public | 18,24,000 shares (agg. up to ₹ 24 Cr) |
| Share Holding Pre Issue | 53,20,000 shares |
| Share Holding Post Issue | 72,40,000 shares |
IPO Date
28 to 30 Jan, 2026
Listing Date
Wed, Feb 4, 2026 T
Face Value
₹ 10 per share
Price Band
₹122 to ₹129
Lot Size
1,000 Shares
Sale Type
Fresh Capital
Issue Type
Bookbuilding IPO
Listing At
BSE SME
Total Issue Size
19,20,000 shares (agg. up to ₹ 25 Cr)
Reserved for Market Maker
96,000 shares (agg. up to ₹ 1 Cr) Sunflower Broking Pvt.Ltd.
Net Offered to Public
18,24,000 shares (agg. up to ₹ 24 Cr)
Share Holding Pre Issue
53,20,000 shares
Share Holding Post Issue
72,40,000 shares
IPO Subscription Details
| Anchor | 1 |
| Market Maker | 1 |
| QIB (Ex Anchor) | 1.01 |
| NII*** | 2.08 |
| bNII (> ₹10L) | 1.95 |
| sNII (< ₹10L) | 2.33 |
| Individual Investors | 2.19 |
| Total ** | 1.83 |
Anchor
1
Market Maker
1
QIB (Ex Anchor)
1.01
NII***
2.08
bNII (> ₹10L)
1.95
sNII (< ₹10L)
2.33
Individual Investors
2.19
Total **
1.83
Day Wise Sub
| Day | QIB (Ex Anchor) | NII* | NII (> ₹10L) | NII (< ₹10L) | Individual Investors | Total |
|---|---|---|---|---|---|---|
| Jan 2 8 (Day 1) | 0.00 | 0.45 | 0.57 | 0.23 | 0.21 | 0.20 |
| Jan 2 9 (Day 2) | 0.99 | 0.64 | 0.48 | 0.98 | 0.43 | 0.64 |
| Jan 3 0 (Day 3) | 1.01 | 2.08 | 1.95 | 2.33 | 2.19 | 1.83 |
DayJan 2
8 (Day 1)
QIB (Ex Anchor)0.00
NII*0.45
NII (> ₹10L)0.57
NII (< ₹10L)0.23
Individual Investors0.21
Total0.20
DayJan 2
9 (Day 2)
QIB (Ex Anchor)0.99
NII*0.64
NII (> ₹10L)0.48
NII (< ₹10L)0.98
Individual Investors0.43
Total0.64
DayJan 3
0 (Day 3)
QIB (Ex Anchor)1.01
NII*2.08
NII (> ₹10L)1.95
NII (< ₹10L)2.33
Individual Investors2.19
Total1.83
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 04-02-2026 | 129.00 | 68(52.71%) | 197 |
| 03-02-2026 | 129.00 | 68(52.71%) | 197 |
| 02-02-2026 | 129.00 | 17(13.18%) | 146 |
| 01-02-2026 | 129.00 | 6(4.65%) | 135 |
| 31-01-2026 | 129.00 | 6(4.65%) | 135 |
| 30-01-2026 | 129.00 | 4(3.10%) | 133 |
| 29-01-2026 | 129.00 | 0(0.00%) | 129 |
| 28-01-2026 | 129.00 | 0(0.00%) | 129 |
| 27-01-2026 | 129.00 | 0(0.00%) | 129 |
| 26-01-2026 | 129.00 | 0(0.00%) | 129 |
| 25-01-2026 | 129.00 | 0(0.00%) | 129 |
| 24-01-2026 | 129.00 | 0(0.00%) | 129 |
| 23-01-2026 | 129.00 | 0(0.00%) | 129 |
| 22-01-2026 | 129.00 | 0(0.00%) | 129 |
| 21-01-2026 | 129.00 | 0(0.00%) | 129 |
| 20-01-2026 | 129.00 | 0(0.00%) | 129 |
Date04-02-2026
Price129.00
GMP68(52.71%)
Estimate List Price197
Date03-02-2026
Price129.00
GMP68(52.71%)
Estimate List Price197
Date02-02-2026
Price129.00
GMP17(13.18%)
Estimate List Price146
Date01-02-2026
Price129.00
GMP6(4.65%)
Estimate List Price135
Date31-01-2026
Price129.00
GMP6(4.65%)
Estimate List Price135
Date30-01-2026
Price129.00
GMP4(3.10%)
Estimate List Price133
Date29-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
Date28-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
Date27-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
Date26-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
Date25-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
Date24-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
Date23-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
Date22-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
Date21-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
Date20-01-2026
Price129.00
GMP0(0.00%)
Estimate List Price129
IPO Important Dates
| IPO Open | Wed, Jan 28, 2026 |
| IPO Close | Fri, Jan 30, 2026 |
| Allotment | Mon, Feb 2, 2026 |
| Refund | Tue, Feb 3, 2026 |
| Credit of Shares | Tue, Feb 3, 2026 |
| Listing | Wed, Feb 4, 2026 |
IPO Open
Wed, Jan 28, 2026
IPO Close
Fri, Jan 30, 2026
Allotment
Mon, Feb 2, 2026
Refund
Tue, Feb 3, 2026
Credit of Shares
Tue, Feb 3, 2026
Listing
Wed, Feb 4, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2,000 | ₹2,58,000 |
| Individual investors (Retail) (Max) | 2 | 2,000 | ₹2,58,000 |
| S-HNI (Min) | 3 | 3,000 | ₹3,87,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,03,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,32,000 |
ApplicationIndividual investors (Retail) (Min)
Lots2
Shares2,000
Amount₹2,58,000
ApplicationIndividual investors (Retail) (Max)
Lots2
Shares2,000
Amount₹2,58,000
ApplicationS-HNI (Min)
Lots3
Shares3,000
Amount₹3,87,000
ApplicationS-HNI (Max)
Lots7
Shares7,000
Amount₹9,03,000
ApplicationB-HNI (Min)
Lots8
Shares8,000
Amount₹10,32,000
Key Performance Indicator
| ROE | 68.54% |
| ROCE | 49.09% |
| Debt/Equity | 0.54 |
| RoNW | 56.50% |
| PAT Margin | 16.59% |
| EBITDA Margin | 23.36% |
| Price to Book Value | 7.71 |
ROE
68.54%
ROCE
49.09%
Debt/Equity
0.54
RoNW
56.50%
PAT Margin
16.59%
EBITDA Margin
23.36%
Price to Book Value
7.71
Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (₹ per share) | P/E (x) | RoNW (%) | P/BV Ratio |
|---|---|---|---|---|---|---|
| Accretion Nutraveda | 4.73 | 4.73 | 16.74 | 56.50 | ||
| Walpar Nutritions | 1.06 | 1.06 | 17.05 | 3.30 | 6.24 | 2.65 |
| Influx Healthtech | 4.81 | 4.81 | 38.98 | 46.99 | 11.10 | 5.95 |
Company NameAccretion Nutraveda
EPS (Basic)4.73
EPS (Diluted)4.73
NAV (₹ per share)16.74
P/E (x)
RoNW (%)56.50
P/BV Ratio
Company NameWalpar Nutritions
EPS (Basic)1.06
EPS (Diluted)1.06
NAV (₹ per share)17.05
P/E (x)3.30
RoNW (%)6.24
P/BV Ratio2.65
Company NameInflux Healthtech
EPS (Basic)4.81
EPS (Diluted)4.81
NAV (₹ per share)38.98
P/E (x)46.99
RoNW (%)11.10
P/BV Ratio5.95
IPO Reservation
| Market Maker Shares Offered | 96,000 (5.00%) |
| QIB Shares Offered | 9,08,000 (47.29%) |
| − Anchor Investor Shares Offered | 5,44,000 (28.33%) |
| − QIB (Ex. Anchor) Shares Offered | 3,64,000 (18.96%) |
| NII (HNI) Shares Offered | 2,76,000 (14.37%) |
| − bNII > ₹10L | 1,84,000 (9.58%) |
| − sNII < ₹10L | 92,000 (4.79%) |
| Retail Shares Offered | 6,40,000 (33.33%) |
| Total Shares Offered | 19,20,000 (100.00%) |
Market Maker Shares Offered
96,000 (5.00%)
QIB Shares Offered
9,08,000 (47.29%)
− Anchor Investor Shares Offered
5,44,000 (28.33%)
− QIB (Ex. Anchor) Shares Offered
3,64,000 (18.96%)
NII (HNI) Shares Offered
2,76,000 (14.37%)
− bNII > ₹10L
1,84,000 (9.58%)
− sNII < ₹10L
92,000 (4.79%)
Retail Shares Offered
6,40,000 (33.33%)
Total Shares Offered
19,20,000 (100.00%)
Information about company
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.
The company operates as a Contract Development and Manufacturing Organization (CDMO) , serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.
Business verticals:
It has a manufacturing facility in Gujarat covers about 10,763 sq. ft., equipped with modern infrastructure, including 13 air handling units, separate processing areas, and quality control systems. The facility is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified, with an FSSAI license.
Competitive Strengths
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Purchase of Machineries for Automation in existing Manufacturing unit 4.22 2 Purchase of Machineries for New Manufacturing Setup 8.03 3 Funding working capital requirements of our company 5.50 4 General corporate purposes 3.69
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App